Personalized prevention civic priority after 20 years defending rights

Twenty years after its launch, the European Patients’ Rights Day event in Brussels highlighted a shift in healthcare priorities across Europe. Organized by Cittadinanzattiva and Active Citizenship Network, the gathering on 12 May 2026 drew over 40 attendees in person from 18 countries and more than 150 online from 34 countries. The focus: making tailored prevention a universal right, not a privilege. The event, held at the European Parliament in Brussels, served as both an anniversary celebration and a critical reflection on the evolving role of citizens in shaping healthcare systems. The discussions emphasized the need to integrate patient voices into every stage of innovation, from research to implementation, ensuring that prevention strategies reflect the diverse needs of European populations.

The anniversary marked two decades of advocacy for patient-centered policies. Today, that vision faces new challenges as healthcare systems grapple with technological advances and rising inequality risks. The event showed the importance of maintaining this foundational principle, even as personalized prevention increasingly relies on complex tools like genomic screening and digital risk assessments. The European Patients’ Rights Day has evolved from a niche initiative to a cornerstone of European health policy, with its 20th anniversary reinforcing its role as a catalyst for institutional dialogue and civic engagement across the continent.

Participants emphasized that innovation alone cannot guarantee equity. Tools like genomic screening and digital risk assessments must be paired with health literacy, public trust, and democratic oversight. Without these, tailored prevention could deepen divides instead of closing them. The event highlighted the risks of a fragmented healthcare setting, where access to advanced prevention tools is determined by socioeconomic status, geographic location, or digital connectivity. This concern was echoed by representatives from the European Patients’ Forum, the European Society of Human Genetics, and EP PerMed, who stressed the need for policies that ensure equitable distribution of resources and opportunities for all citizens, regardless of background.

The event drew on the PROPHET project’s research, which outlines priorities for implementing tailored prevention. These include improving data governance, ensuring equitable access to innovation, and supporting citizen participation in healthcare decisions. The PROPHET project, coordinated by Università Cattolica del Sacro Cuore, provided a Strategic Research and Innovation Agenda that identifies concrete steps to bridge gaps in health literacy and data privacy. This framework was central to the discussions, as participants explored how to balance the benefits of personalized medicine with the ethical and logistical challenges of data sharing and patient autonomy.

Participants emphasized the danger of a “two-speed” system, where only some citizens benefit from advanced prevention tools. The event also addressed the economic implications of this imbalance, with stakeholders from EFPIA and the European Commission emphasizing the long-term cost savings of investing in prevention. The central

Local initiatives across Europe have long supported the Patients’ Rights Day. Since 2002, the event has become a platform for dialogue between institutions and civil society. This year’s gathering reinforced its role in shaping healthcare policies that prioritize dignity and equality. The anniversary also marked a moment of civic pride for Cittadinanzattiva and Active Citizenship Network, whose efforts since 2002 have transformed the event into a pan-European movement. From grassroots campaigns to institutional partnerships, the event’s legacy is reflected in the growing number of local initiatives that align with its mission of empowering patients and promoting inclusive healthcare reforms.

The anniversary also highlighted the need for stronger safeguards. Tailored prevention requires not only scientific investment but also policies that ensure no citizen is excluded from its benefits. As Europe’s healthcare systems face growing pressures, this approach could redefine public health strategies. The event’s emphasis on democratic oversight and citizen participation was reinforced by the endorsement of the MEPs Interest Group “European Patients’ Rights & Cross-Border Healthcare,” which showed the importance of cross-border collaboration in addressing health disparities. The celebration was hosted by MEP Brando Benifei (S&D, Italy) and supported by sponsors including MSD, Redcare Pharmacy, and Viatris, whose contributions reflected a shared commitment to transforming healthcare through inclusive, citizen-driven innovation.